Abicipar Pegol Completed Phase 3 Trials for Macular Degeneration Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02462486 | Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration | |
| NCT02462928 | A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration |